SEGMENTS (Tables)

3 Months Ended

Mar. 31, 2022

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the three months ended March 31, 2022 and 2021:

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Three Months Ended on March 31, 2022
Revenue	$	1,274,106		$	-		$	617,471		$	60,660		$	1,952,237
Cost of Sales		(1,093,709	)		-			(12,038	)		(8,803	)		(1,114,550	)
Gross Margin		180,397			-			605,433			51,857			837,687
Operating Expenses		(536,765	)		(114,263	)		(620,342	)		(1,219,858	)		(2,491,228	)
Operating Loss		(356,368	)		(114,263	)		(14,909	)		(1,168,001	)		(1,653,541	)
Other Income (Expense)		98			(455,000	)		(1,205,349	)		(4,394,547	)		(6,054,798	)
Net Loss Before Income Tax		(356,270	)		(569,263	)		(1,220,258	)		(5,562,548	)		(7,708,339	)

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Three Months Ended on March 31, 2021
Revenue	$	3,894,131		$	-		$	1,712,783		$	-		$	5,606,914
Cost of Sales		(3,614,832	)		-			(83,022	)		-			(3,697,854	)
Gross Margin		279,299			-			1,629,761			-			1,909,060
Operating Expenses		(359,489	)		(30,128	)		(846,480	)		(1,076,408	)		(2,312,505	)
Operating (Loss) Income		(80,190	)		(30,128	)		783,281			(1,076,408	)		(403,445	)
Other Expense		(9,873	)		(36,471	)		(8,371,117	)		(532,505	)		(8,949,966	)
Net Loss Before Income Tax		(90,063	)		(66,599	)		(7,587,836	)		(1,608,913	)		(9,353,411	)
March 31, 2022
Cash and Restricted Cash	$	4,613,299		$	210,576		$	2,443,494		$	46,778,784		$	54,046,153
Total Assets		53,290,942			1,708,769			9,199,987			128,630,889			192,830,587
December 31, 2021
Cash and Restricted Cash	$	7,493,921		$	245,780		$	2,629,464		$	50,433,014		$	60,802,179
Total Assets		55,465,600			2,199,466			11,056,779			115,488,298			184,210,143